Vancouver’s AbCellera has acquired Trianni in an all-cash transaction valued at US $90 million. Trianni’s genetic engineering technology is a platform for developing humanized mice. The acquisition deepens AbCellera’s technology stack with a suite of genetically engineered mice for generating diverse panels of human antibodies with drug-like properties. “Trianni marks our fourth and largest strategic […]
AbCellera
AbCellera, Cymax, Klue, Thinkific, and Unbounce Hiring Virtually Next Week
It’s a great time to be looking for a new gig in Vancouver’s tech ecosystem and Tech Talent Canada is making it easier than ever with their upcoming virtual job fair. Tech Talent Canada’s job fairs have been a huge success with 1,500+ educated, experienced, and diverse candidates at each of their events since they […]
Vancouver UX Awards Finalists Announced
The Vancouver User Experience Awards is an opportunity for growing startups, freelance practitioners, agencies, and user-centric enterprises to showcase their work and get recognized for the incredible experiences they create every day. This year’s Vancouver UX Awards finalists highlight the benefits of interactive media in health, sport and knowledge sharing. The five awards, including the […]
79 Career Opportunities At Vancouver’s Award Winning Tech Companies
It’s a great time to be looking for a new gig in Vancouver’s tech ecosystem. The city just ranked first for high-tech software job growth, leading the top tech markets in the US and Canada with a growth rate of 29.2% over the past two years. Last week ten companies were honoured at the 2020 […]
BC Technology Impact Award Winners Announced
This year the winners of the 2020 Technology Impact Awards (TIAs) were announced virtually. Unlike previous years where the winners were showered with attention at an in-person gala event, this year the awards were presented online. Produced by the BC Tech Association, the TIA awards represent the cream of an impressive crop of innovative ventures […]
AbCellera Partners With Kodiak Sciences To Prevent And Treat Blindness
AbCellera has announced a new partnership with Kodiak Sciences to generate therapeutic antibody candidates in ophthalmology. Following a previously successful collaboration, AbCellera will use its full stack, AI-powered antibody discovery technology to discover and identify a large panel of antibodies against new targets designated by Kodiak. “Kodiak was one of AbCellera’s very first partners, and […]
AbCellera’s Antibody Progresses to Phase 3 Clinical Trials
AbCellera has announced that LY-CoV555, a human antibody discovered by AbCellera in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID) Vaccine Research Center (VRC) and co-developed with Lilly as a potential treatment and prophylaxis for COVID-19, has progressed to Phase 3 clinical trials. A first-of-its-kind, the Lilly-sponsored trial will use customized mobile […]
AbCellera Wins Fast Company’s Innovative Team of the Year Award
Fast Company Magazine has published their second annual list of the Best Workplaces for Innovators. The list identifies companies that encourage bold experimentation, not just from the C-suite or engineering groups but from every level of the organization. And now more than ever, businesses of every kind, from every industry, must innovate to survive and […]
Eli Lilly Starts First Human Trials of AbCellera’s COVID-19 Treatment
AbCellera today announced that LY-CoV555, the lead antibody from the collaboration between AbCellera and Eli Lilly, has entered into human testing for the potential treatment of COVID-19. LY-CoV555 is developed from a fully human monoclonal antibody identified from the first blood sample obtained from a North American patient who recovered from COVID-19. Developed at record […]
Peter Thiel And More Double Down On AbCellera’s COVID-19 Antibody Drugs
AbCellera has raised another round of financing, this time a US $105 million Series B round. The financing was led by OrbiMed and current investor DCVC Bio, with an investor syndicate that includes Viking Global Investors, Peter Thiel, Founders Fund, Eli Lilly and Company, University of Minnesota, and Presight Capital. Earlier this month the Government […]